References
Arzneimittelkommission der Deutschen ärzteschaft (1983) Strenge Indikationsstellung bei Ketoconazol-Verordnung. Dtsch Ärztebl Ausg C, 80/21:68
Berman JD (1982) In vitro susceptibility of antimony-resistant Leishmania to alternative drugs. J Infect Dis 145:279
Heeres J, Backx LJJ, Mostmans JH, Van Cutsem J (1979) The synthesis and antifungal activity of ketoconazole, a new potent orally active broadspectrum antifungal agent. J Med Chem 22:1003–1007
Pfaller MA, Krogstad DJ (1981) Imidazole and polyene activity against chloroquine-resistantPlasmodium falciparum J Infect Dis 144:372–375
Pont A (1982) Ketoconazole inhibits adrenal steroid synthesis. Clin Res 30:520A
Raether W, Seidenath H (1983) The activity of fexinidazole (HOE 239) against experimental infections withTrypanosoma cruzi, trichomonads andEntamoeba histolytica. Ann Trop Med Parasitol 77:13–26
Ryley JF, Wilson RG (1982) ICI 153,066 a new, orally-active antifungal agent, 22nd Interscience conference on antimicrobial agents and chemotherapy, Miami Beach, Florida, USA
Schürmeyer TH, Nieschlag E (1982) Ketoconazole-induced drop in serum and saliva testosterone. Lancet, Nov. 13:1098
Stauber LA, Franchino EM, Grun J (1958) An eight-day method for screening compounds againstLeishmania donovani in the golden hamster. J Protozool 5:269–273
Urcuyo FG, Zaias N (1982) Oral ketoconazole in the treatment of leishmaniasis. Int J Derm 21:414–416
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Raether, W., Seidenath, H. Ketoconazole and other potent antimycotic azoles exhibit pronounced activity againstTrypanosoma cruzi, Plasmodium berghei andEntamoeba histolytica in vivo. Z. Parasitenkd. 70, 135–138 (1984). https://doi.org/10.1007/BF00929583
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00929583